default author photo

Francisco Vega

UT MD Anderson Cancer Center

Professor and lymphoma section head

SCHOLARLY PAPERS

2

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Rewiring BCL6 with Transcriptional/epigenetic Chemical Inducers of Proximity Unveils Targetable Plasticity in Large B Cell Lymphoma

Number of pages: 61 Posted: 16 Jun 2026
University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, Stanford University, Stanford University, University of Texas at Houston - Department of Lymphoma and Myeloma, Stanford University, Stanford University, University of Texas at Houston - Graduate School of Biological Sciences, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, Stanford University, University of Texas at Houston - Department of Lymphoma and Myeloma, Mayo Clinic, Emory University, Cornell University - Pathology and Laboratory Medicine, UT MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - MD Anderson Cancer Center, Stanford University - Howard Hughes Medical Institute, Stanford University - Department of Chemical and Systems Biology, University of Texas at Houston - Department of Lymphoma and Myeloma and Independent
Downloads 49

Abstract:

Loading...

Lymphoma, BCL6, epigenetics, plasticity

2.

Targetable Cellular Etiology of Prolonged Cytopenia Following CD19 CAR T-Cell Therapy

Number of pages: 37 Posted: 09 Nov 2022
University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma/Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Lymphoma and Myeloma, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, University of Texas at Houston - Department of Lymphoma and Myeloma and University of Texas at Houston - Department of Lymphoma and Myeloma
Downloads 33 (1,277,121)

Abstract:

Loading...

CAR T-cell, B-cell lymphoma, Cytopenia, Interferon